Announce Date | 02/20/2025 |
EPS Normalized Actual | $0.14 (Beat by $0.03) |
EPS GAAP Actual | $0.14 (Beat by $0.03) |
Revenue Actual | $0.332197B |
Revenue Surprise | Beat by $332.197M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 1.29612 | 27.42 | 1.18241 | 1.39924 | 8 |
Dec 2027 | 0 | INF | 0 | 0 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.1 | -0.1 | 0.332197B | -4.59% | 332.2M |
FQ3 2024 (Sep 2024) | 0.0428 | 0.0428 | 0.265748B | -44.78% | 265.75M |
FQ2 2024 (Jun 2024) | 0.29 | 0.29 | 0.401977B | 18.93% | 401.98M |
FQ1 2024 (Mar 2024) | 0.28 | 0.28 | 0.355708B | 26.92% | 355.71M |
FQ4 2023 (Dec 2023) | 0.76 | 0.76 | 0.347435B | 100% | 347.44M |
FQ4 2012 (Dec 2012) | -0.0054 | -0.0054 | 0.00193322B | 100% | 1.93M |
FQ1 2013 (Mar 2013) | -0.0067 | -0.0067 | 0.00234237B | 100% | 2.34M |
FQ2 2013 (Jun 2013) | -0.0038 | -0.0038 | 0.00301876B | 100% | 3.02M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 4 |
FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 3 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 3 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 7 |
FQ4 2026 (Oct 2026) | 0.64083 | -- | 0.59272 | 0.70728 | 3 |
FQ3 2026 (Jul 2026) | 0.51115 | -- | 0.47277 | 0.56415 | 3 |
FQ2 2026 (Jun 2026) | 0.51115 | -- | 0.47598 | 0.55976 | 3 |
FQ1 2026 (Mar 2026) | 0.36575 | -- | 0.34059 | 0.40053 | 6 |
FQ4 2025 (Oct 2025) | 0.48504 | 120.62 | 0.44862 | 0.53533 | 4 |
FQ3 2025 (Sep 2025) | 0.48725 | 91.22 | 0.45373 | 0.53359 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.87B | -- | 0.82B | 0.94B | 5 |
FQ3 2027 (Jul 2027) | 0.76B | -- | 0.71B | 0.82B | 5 |
FQ2 2027 (Jun 2027) | 0.76B | -- | 0.72B | 0.81B | 5 |
FQ1 2027 (Mar 2027) | 0.65B | -- | 0.62B | 0.7B | 5 |
FQ4 2026 (Oct 2026) | 0.9B | -- | 0.85B | 0.97B | 5 |
FQ3 2026 (Jul 2026) | 0.76B | -- | 0.72B | 0.83B | 5 |
FQ2 2026 (Jun 2026) | 0.76B | -- | 0.72B | 0.82B | 5 |
FQ1 2026 (Mar 2026) | 0.64B | -- | 0.61B | 0.69B | 5 |
FQ4 2025 (Oct 2025) | 0.71B | 53.35 | 0.67B | 0.77B | 4 |
FQ3 2025 (Sep 2025) | 0.72B | 63.1 | 0.68B | 0.77B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.1 | -0.1 | 100% | |
FQ3 2024 (Sep 2024) | 0.0428 | 0.0428 | 100% | |
FQ2 2024 (Jun 2024) | 0.29 | 0.29 | 100% | |
FQ1 2024 (Mar 2024) | 0.28 | 0.28 | 100% | |
FQ4 2023 (Dec 2023) | 0.76 | 0.76 | 100% | |
FQ4 2012 (Dec 2012) | -0.0054 | -0.0054 | 100% | |
FQ1 2013 (Mar 2013) | -0.0067 | -0.0067 | 100% | |
FQ2 2013 (Jun 2013) | -0.0038 | -0.0038 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.33B | $332.2M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.27B | $265.75M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.4B | $401.98M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.36B | $355.71M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.35B | $347.44M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0B | $1.93M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0B | $2.34M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0B | $3.02M | 100% |